Gastrointestinal stromal tumor

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal (GI) tract, typically presenting in adults over the age of 40 (mean age 63), and only rarely in children, in various regions of the GI tract, most commonly the stomach or small intestine but also less commonly in the esophagus, appendix, rectum and colon. GISTs can be asymptomatic or present with various non-specific signs, depending on the location and size of tumor, such as loss of appetite, anemia, weight loss, fatigue, abdominal discomfort or fullness, nausea, vomiting, as well as an abdominal mass, blood in stool, and intestinal obstruction. GISTs can also be seen in familial syndromes such as Carney triad and neurofibromatosis type 1.

Extrahepatic cholestasis

Impairment of bile flow due to obstruction in large bile ducts outside the liver.


Total: 2

                      


(per page)
PMID (PMCID)
20352594
MALE Middle Aged
Gastrointestinal stromal tumor in a patient with undiagnosed neurofibromatosis type I: an uncommon cause of extrahepatic cholestasis.
Millonig G, Giesel FL, Reimann FM, Topalidis T, Seitz HK, Mueller S.
Z Gastroenterol. 2010;48(4):479-81.
Gastrointestinal stromal tumor in a patient with undiagnosed neurofibromatosis type I: an uncommon cause of extrahepatic cholestasis.
12394270
MALE Middle Aged
Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.
Bauer S, Hagen V, Pielken HJ, Bojko P, Seeber S, Schutte J.
Anticancer Drugs. 2002;13(8):847-9.
Hepatic and peritoneal metastases are the most frequent metastatic lesions in patients with gastrointestinal stromal tumors (GIST), and may result in intra- or extrahepatic cholestasis and altered drug metabolism.